California
Duarte; City of Hope
RTOG 0525: Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma
Duarte; City of Hope
A Pilot Feasibility Study of Intracerebral Microdialysis to Determine the Neuropharmacokinetics of Temozolomide
Duarte; City of Hope
A Pharmacokinetic and Pharmacogenomic Study of Patients with High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide
Duarte; City of Hope
COG ANBL0032: Phase III Randomized Study Of Chimeric Antibody 14.18 (CH14.18) In High Risk Neuroblastoma Following Myeloablative Therapy And Autologous Stem Cell Rescue
Duarte; City of Hope
Evaluation of the use of Poxvirus Vaccines to Stimulate P53 Specific Immunity
Florida
Orlando; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Orlando; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Illinois
Evanston; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Massachusetts
Boston; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Boston; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
New Hampshire
Lebanon; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
New Jersey
Edison; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Summit; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
New York
Manhasset; Biomedical Research Alliance of New York
Recurrent Glioblastoma Multiforme (Brain Tumor) - Adults
New York; Columbia University Department of Neurosurgery
This study will evaluate the effectiveness and safety of a drug named Topotecan as it is given directly into brain tumors by a technique called "Intracerebral Clysis" (ICC) in patients with malignant brain tumors.
New York; Biomedical Research Alliance of New York
Primary Brain Cancer - Adults
New York; Biomedical Research Alliance of New York
Brain Tumor [Glioblastoma Multiforme (GBM)] - Adults
New York; Biomedical Research Alliance of New York
Malignant Glioma (Cancerous tumor in the brain) - Adults
Texas
Dallas; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Dallas; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
